• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HAM56抗体:结直肠癌与妇科恶性肿瘤鉴别诊断的一种工具。

HAM56 antibody: a tool in the differential diagnosis between colorectal and gynecological malignancy.

作者信息

Younes M, Katikaneni P R, Lechago L V, Lechago J

机构信息

Department of Pathology, Baylor College of Medicine, Methodist Hospital, Houston, Texas.

出版信息

Mod Pathol. 1994 Apr;7(3):396-400.

PMID:8058715
Abstract

HAM56, a monoclonal antibody first used to identify macrophages and endothelial cells, also stains many carcinomas (except those arising in the digestive tract). This property is useful in the differentiation between primary ovarian and metastatic colonic carcinomas in the ovary, or between gynecological (ovarian and endometrial) and colonic implants and lymph node metastases. This distinction is important as the prognoses of colorectal and gynecological malignancies differ significantly. Sixteen primary ovarian carcinomas (10 with peritoneal implants and 3 with lymph node metastases), eight cases of primary colonic carcinomas (four metastatic to ovary, four with peritoneal implants, and four with lymph node metastases), and three primary endometrial carcinomas, all with metastases to the ovary, were immunostained with the HAM56 antibody using the ABC immunoperoxidase technique. Linear membranous immunostaining was considered positive, whereas staining of mucin and debris was regarded as negative. Using these parameters, 15/16 ovarian primaries, 9/10 ovarian implants, 3/3 ovarian lymph node metastases, and 3/3 endometrial primaries and their ovarian metastases were positive. Colonic primaries, their ovarian metastases, peritoneal implants, and lymph node metastases were all negative. It is concluded that the HAM56 antibody is a useful tool in the distinction between colorectal and ovarian malignancies in those cases where the routine histological appearance may be ambiguous.

摘要

HAM56是一种单克隆抗体,最初用于识别巨噬细胞和内皮细胞,它也能使许多癌组织(消化道起源的癌除外)染色。这一特性有助于鉴别原发性卵巢癌与卵巢转移性结肠癌,或鉴别妇科(卵巢和子宫内膜)植入物及淋巴结转移灶与结肠植入物及淋巴结转移灶。这种鉴别很重要,因为结直肠癌和妇科恶性肿瘤的预后有显著差异。采用ABC免疫过氧化物酶技术,用HAM56抗体对16例原发性卵巢癌(10例有腹膜植入物,3例有淋巴结转移)、8例原发性结肠癌(4例转移至卵巢,4例有腹膜植入物,4例有淋巴结转移)以及3例均有卵巢转移的原发性子宫内膜癌进行免疫染色。线性膜状免疫染色被视为阳性,而黏液和碎片的染色则视为阴性。根据这些参数,16例原发性卵巢癌中有15例、10例卵巢植入物中有9例、3例卵巢淋巴结转移中有3例以及3例原发性子宫内膜癌及其卵巢转移灶均呈阳性。结肠癌原发性肿瘤、其卵巢转移灶、腹膜植入物及淋巴结转移灶均为阴性。结论是,在常规组织学表现可能不明确的情况下,HAM56抗体是鉴别结直肠癌和卵巢恶性肿瘤的有用工具。

相似文献

1
HAM56 antibody: a tool in the differential diagnosis between colorectal and gynecological malignancy.HAM56抗体:结直肠癌与妇科恶性肿瘤鉴别诊断的一种工具。
Mod Pathol. 1994 Apr;7(3):396-400.
2
Correspondence re: Mamoun Younes et al.: HAM56 antibody: a tool in the differential diagnosis between colorectal and gynecological malignancy. Mod Pathol 7:396, 1994.通信:关于Mamoun Younes等人:HAM56抗体:结直肠癌与妇科恶性肿瘤鉴别诊断的工具。《现代病理学》7:396,1994年。
Mod Pathol. 1995 Apr;8(3):343-4.
3
Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma.
Mod Pathol. 1996 Apr;9(4):426-9.
4
Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma.细胞角蛋白免疫染色在鉴别原发性卵巢癌与转移性结肠腺癌中的应用
Mod Pathol. 1996 Nov;9(11):1040-4.
5
Monoclonal anti-CEA antibodies in the discrimination between primary pulmonary adenocarcinoma and colon carcinoma metastatic to the lung.单克隆抗癌胚抗原抗体在鉴别原发性肺腺癌和肺转移结肠癌中的应用
Mod Pathol. 1990 Sep;3(5):613-8.
6
Is immunostaining with HAM56 antibody useful in identifying ovarian origin of metastatic adenocarcinomas?使用HAM56抗体进行免疫染色对识别转移性腺癌的卵巢起源是否有用?
Hum Pathol. 1997 Jan;28(1):91-4. doi: 10.1016/s0046-8177(97)90285-9.
7
Pulmonary metastases of colonic carcinoma. Distinction from pulmonary adenocarcinoma.结肠癌的肺转移。与肺腺癌的鉴别。
Arch Pathol Lab Med. 1992 Jan;116(1):39-42.
8
[Immunohistochemical flow chart to differentiate between primary adenocarcinoma and the most frequent extragynecological metastases in the ovary].
Rev Med Chil. 2002 Nov;130(11):1232-40.
9
Incidence of microsatellite instability in synchronous tumors of the ovary and endometrium.卵巢和子宫内膜同步肿瘤中微卫星不稳定性的发生率。
Clin Cancer Res. 2003 Apr;9(4):1387-92.
10
Reactivity of monoclonal antibody F36/22 with human ovarian adenocarcinomas.单克隆抗体F36/22与人卵巢腺癌的反应性。
Cancer Res. 1984 May;44(5):1954-62.

引用本文的文献

1
Recent advances in immunohistochemistry in the diagnosis of ovarian neoplasms.免疫组织化学在卵巢肿瘤诊断中的最新进展
J Clin Pathol. 2000 May;53(5):327-34. doi: 10.1136/jcp.53.5.327.